A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod

A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod

Agonists for toll-like receptors (TLRs) have shown promising activities against cancer. In the present study, a squalene-based nanoemulsion (NE) was loaded with resiquimod, a TLR7/8 agonist for therapeutic delivery. R848 NE was developed and characterized for long-term stability. In vitro and in viv...

Full description

Bibliographic Details
Main Authors: Zhongkun Zhang, Jimmy Chun-Tien Kuo, Chi Zhang, Yirui Huang, Zerui Zhou, Robert J. Lee
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Pharmaceutics
Subjects:
nanoemulsions
TLR agonists
solid tumors
SD-101
resiquimod
Online Access:https://www.mdpi.com/1999-4923/13/12/2060

Internet

https://www.mdpi.com/1999-4923/13/12/2060

Similar Items